Stockscreener 앱 받기
31.44
4.96%
-1.64
시간 외 거래:
31.66
0.22
+0.70%
Vericel Corp 주식(VCEL)의 최신 뉴스
Vericel (NASDAQ:VCEL) Stock Price Down 4.9%Time to Sell? - MarketBeat
Vericel corp director Hagen sells $486k in shares - Investing.com
Vericel (VCEL) director sells 15,000 shares after option exercise - Stock Titan
Vericel Corporation $VCEL Position Increased by Congress Asset Management Co. - MarketBeat
[144] Vericel Corp SEC Filing - Stock Titan
Vericel Corp ($VCEL) CEO 2025 Pay Revealed - Quiver Quantitative
VCEL Stock Price, Quote & Chart | VERICEL CORP (NASDAQ:VCEL) - ChartMill
Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Market Challenges - Markets Mojo
What Makes Vericel Corporation (VCEL) an Investment Bet? - Yahoo Finance
Dilated Cardiomyopathy Market: Rapid Growth & Investment Outlook to 2034 – DelveInsight | Bristol Myers Squibb, Berlin Cures, Cumberland Pharma, Vericel Corp, Corimmun GmbH, Pfizer, Constant Therapeut - Barchart
Dilated Cardiomyopathy Market: Rapid Growth & Investment - openPR.com
Bank Watch: Can Vericel Corporation sustain earnings growth2026 Recap & Safe Entry Point Alerts - baoquankhu1.vn
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion By Investing.com - Investing.com Australia
Vericel at Leerink Global Healthcare: Strategic Growth and Expansion - Investing.com South Africa
Leerink reiterates Outperform on Vericel stock, $46 target - Investing.com
FDA MACI Approval Tests Vericel’s Capacity Plans And Growth Story - Yahoo Finance
Vericel Corporation (VCEL) Secures FDA Approval for Commercial Manufacturing of MACI - Finviz
Vericel (VCEL) Valuation In Focus After FDA Clears MACI Commercial Manufacturing Capacity - simplywall.st
Vericel (NASDAQ:VCEL) Downgraded by Wall Street Zen to Hold - MarketBeat
Vericel (VCEL) Is Down 9.8% After FDA Clears New MACI Plant – Has The Bull Case Changed? - simplywall.st
Vericel wins FDA approval for MACI production at new facility - Investing.com
Insider Sell: Michael Halpin Sells 10,305 Shares of Vericel Corp (VCEL) - GuruFocus
Vericel wins FDA approval for MACI production at new facility By Investing.com - Investing.com Canada
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion By Investing.com - Investing.com Australia
FDA Greenlights Vericel (VCEL) Facility for MACI Production - GuruFocus
Vericel Announces FDA Approval of New State-of-the-Art Advanced Therapy Manufacturing Facility - The Manila Times
FDA approves new Vericel cell therapy plant to expand cartilage repair - Stock Titan
Vericel at TD Cowen Conference: Strong Growth and Strategic Expansion - Investing.com
Sports injury and burn care firm Vericel heads to investor conferences - Stock Titan
Affiliate sale notice for Vericel (NASDAQ: VCEL) — 15,000 shares listed - Stock Titan
VCEL (NASDAQ: VCEL) Form 144 lists vested share sale entries - Stock Titan
H.C. Wainwright raises Vericel stock price target on revenue growth By Investing.com - Investing.com Canada
William Blair Investment Management LLC Buys 1,048,864 Shares of Vericel Corporation $VCEL - MarketBeat
H.C. Wainwright raises Vericel stock price target on revenue growth - Investing.com
Equities Analysts Offer Predictions for Vericel Q4 Earnings - Defense World
HC Wainwright Boosts Vericel (NASDAQ:VCEL) Price Target to $64.00 - Defense World
A Look At Vericel (VCEL) Valuation After Record 2025 Results And Upbeat 2026 Growth Guidance - Yahoo Finance
Should You Buy Vericel Corp (VCEL) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
VCEL Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Vericel (NASDAQ:VCEL) Given New $64.00 Price Target at HC Wainwright - MarketBeat
VCEL Analyst Rating: HC Wainwright & Co. Raises Price Target | V - GuruFocus
Vericel Corporation (NASDAQ:VCEL) Q4 2025 Earnings Call Transcript - Insider Monkey
Vericel Corp (NASDAQ:VCEL) Presents a Compelling Growth and Breakout Case - ChartMill
Vericel (VCEL) EPS Jump In Q4 2025 Tests Premium 115x P/E Narrative - simplywall.st
Decoding Vericel Corp (VCEL): A Strategic SWOT Insight - GuruFocus
Vericel Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Vericel (NASDAQ:VCEL) Issues Quarterly Earnings Results - MarketBeat
Vericel (VCEL) CEO logs RSU vesting, phantom stock deferral and tax shares - Stock Titan
Vericel (VCEL) CMO logs RSU vesting, phantom stock and tax share withholdings - Stock Titan
RSU vesting boosts Vericel (VCEL) officer Siegal’s shareholding - Stock Titan
Vericel (VCEL) CFO logs RSU vesting and tax withholding share dispositions - Stock Titan
COO at Vericel (VCEL) gains stock through RSU vesting and tax withholding - Stock Titan
Vericel (VCEL) CLO reports RSU vesting, share withholding for taxes - Stock Titan
Vericel (VCEL) Q4 2025 Earnings Call Transcript - AOL.com
Vericel Corporation (VCEL) Matches Q4 Earnings Estimates - Yahoo Finance
Vericel Q4 2025 slides: record margins offset by 2026 guidance - Investing.com
Earnings call transcript: Vericel beats Q4 2025 forecasts, stock dips By Investing.com - Investing.com Australia
Earnings call transcript: Vericel beats Q4 2025 forecasts, stock dips - Investing.com India
Vericel Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Vericel Corp (NASDAQ:VCEL) Reports Q4 2025 Earnings In Line, Beats on Profitability - ChartMill
Vericel Corp Ord earnings beat by $0.06, revenue topped estimates - Investing.com Canada
1.82%
자본화:
|
볼륨(24시간):